Antiretroviral Agents in HIV-1 Infected Adults and Adolescents Guidelines Pocket Guide - Guideline Central

Antiretroviral Agents in HIV-1 Infected Adults and Adolescents

United States Department of Health and Human ServicesPublished: August 28, 2019

A PDF version of this Pocket Guide is also available!
$15.95
  • Key Points
  • Baseline Evaluation
  • Drug Resistance Testing
  • HLA-B*5701 Screening
  • Coreceptor Tropism Assays
  • Management of the Treatment-Experienced Patient
  • Tables
    • Indications for Initiating Antiretroviral (ARV) Therapy
    • Coinfections
    • Regimens for ARV Therapy– Naive Patients
    • ARV Regimens That Should Not Be Offered
    • Detailed Characteristics of all ARV Agents
    • Laboratory Monitoring
    • Advantages and Disadvantages of Antiretroviral Components
  • Regimen Simplification

You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.